Stock VSBC VITASPRING BIOMEDICAL CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company VitaSpring Biomedical Co. Ltd.

Equities

VSBC

US92851B1026

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 02:03:41 2023-08-11 pm EDT 		5-day change 1st Jan Change
15 USD +36.24% Intraday chart for VitaSpring Biomedical Co. Ltd. -.--% -.--%
2022 VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022 CI
2022 VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022 CI

Business Summary

Vitaspring Biomedical Co. Ltd. is focused on cell medical industry. The Company is engaged in the business of developing and marketing products that promote wellness and a healthy lifestyle. The Company invests in research and development of stem cell applications in regenerative medicine, establish advanced medical research centers and cell production centers and provides GTP standard stem cell preparations for the development of cellular drugs. The Company is focused on the fields of medicine, preventive health care, beauty, and anti-aging. It is also focused on developing X.MSC cytopharmaceuticals.

Sales per Business

USD in Million2021Weight2022Weight Delta
Cellular Drugs
100.0 %
0 100.0 % 6 100.0 % +2,161.56%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
0 100.0 % 6 100.0 % +2,161.56%

Managers

Managers TitleAgeSince
Cheng Hsiang Kao CEO
 Chief Executive Officer - 20-01-20
Pao Chi Chu CHM
 Chairman 70 20-01-20
Jer Li Lin CTO
 Chief Tech/Sci/R&D Officer - 20-01-20
Yen Xun Chen PRN
 Corporate Officer/Principal - 20-01-20

Members of the board

Members of the board TitleAgeSince
Pao Chi Chu CHM
 Chairman 70 20-01-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 206,520,030 85,148,035 ( 41.23 %) 0 41.23 %

Company contact information

VitaSpring Biomedical Co. Ltd.

400 Spectrum Center Drive Suite 1620

92618, Irvine

+

address VitaSpring Biomedical Co. Ltd.(VSBC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VITASPRING BIOMEDICAL CO. LTD. Stock VitaSpring Biomedical Co. Ltd.
-.--% 3.11B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.26% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+1.41% 95.71B
ARGENX SE Stock argenx SE
+0.73% 22.02B
BIONTECH SE Stock BioNTech SE
-17.84% 20.9B
GENMAB A/S Stock Genmab A/S
-9.33% 17.85B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.83% 16.21B
BEIGENE, LTD. Stock BeiGene, Ltd.
-17.63% 15.52B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+4.55% 13.86B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+32.11% 12.04B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VSBC Stock
  4. Company VitaSpring Biomedical Co. Ltd.